Genome-wide association analysis of age-at-onset in Alzheimer's disease
Year: 2011
Type: article
Study design: Observational Study
Source: Molecular Psychiatry
DOI: 10.1038/mp.2011.135
Authors: M I Kamboh, M M Barmada, F Y Demirci, R L Minster, M M Carrasquillo, V S Pankratz, S G Younkin, A J Saykin, The Alzheimer's Disease Neuroimaging Initiative, R A Sweet, E Feingold, S T DeKosky, O L Lopez
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Funders: Alzheimer's Association, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Novartis, F. Hoffmann-La Roche, Medpace, Synarc, Alzheimer's Disease Neuroimaging Initiative, Northern California Institute for Research and Education, Elan, Eisai, National Institutes of Health, U.S. Food and Drug Administration, Genentech, University of California, Los Angeles, University of California, San Diego, National Institute on Aging
Awards: G104586243, UC Davis Alzheimer's Disease Core Center, Indiana Alzheimer Disease Center, G2152643862, G2409989180, G2835601961, G29951154, Plasma AB as a Surrogate Genetic Marker for LOAD, Alzheimer's Disease Research Center, G3131374986, G3146424788, G3218891203, G3553156159, G3710456697, G3870774570, G3966393351, "MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies", G43180419, G4660785924, Search for the Alzheimers Genes, G5207404921, G5209990037, Alzheimer's Disease Neuroimaging Initiative, G598830915, G6069485058, G6259281481, G6412110892, G6425121803, Prediction of Psychosis in Alzheimer Disease, G6899163935, G6948409098, G7315666996, Memory Circuitry in MCI and Early Alzheimerâs Disease Prodrome: Molecular Drivers, Amyloid Imaging, VMCI, and Analysis for ADNI, G7799614282, G781725486, G793122433, G8636843673, G9000039018, G9000122335, National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), G991187644
OpenAlex ID: W2059835894